| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.0019 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |